Invention Grant
- Patent Title: Carbonate prodrugs and methods of using the same
-
Application No.: US16459430Application Date: 2019-07-01
-
Publication No.: US11136342B2Publication Date: 2021-10-05
- Inventor: Naweed Muhammad , Keith R. Bley
- Applicant: Acorda Therapeutics, Inc.
- Applicant Address: US NY Ardsley
- Assignee: Acorda Therapeutics, Inc.
- Current Assignee: Acorda Therapeutics, Inc.
- Current Assignee Address: US NY Ardsley
- Agency: Morrison & Foerster LLP
- Main IPC: C07F9/09
- IPC: C07F9/09 ; A61K31/661 ; A61K47/54 ; C07C233/25 ; C07F9/11

Abstract:
The present invention provides carbonate prodrugs which comprise a carbonic phosphoric anhydride prodrug moiety attached to the hydroxyl or carboxyl group of a parent drug moiety. The prodrugs may provide improved physicochemical properties over the parent drug. Also provided are methods of treating a disease or condition that is responsive to the parent drug using the carbonate prodrugs, as well as kits and unit dosages.
Public/Granted literature
- US20200157126A1 CARBONATE PRODRUGS AND METHODS OF USING THE SAME Public/Granted day:2020-05-21
Information query